Live Quote · NASDAQATXSHealthcare· Biotechnology

Astria Therapeutics, Inc.

$12.58 0.00%(+$0.00)
TickerSpark Score
62/100
Mixed
65
Valuation
40
Profitability
60
Growth
84
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATXS research report →

52-Week Range93% of range
Low
$3.56
Current
$12.58
High
$13.29
Company Overviewwww.astriatx.com

About the company

Astria Therapeutics, Inc. is a biopharmaceutical company based in Boston, Massachusetts, established in 2008. The firm specializes in identifying, advancing, and bringing to market treatments for uncommon and specialized allergic and immunological disorders across the United States.

CEO
Jill C. Milne
IPO
2015
Employees
78
HQ
Boston, MA, US

Price Chart

+66.62% · this period
$13.20$8.47$3.75Jan 23Jul 25Jan 23
Valuation
Market Cap
$718.13M
P/E
-7.42
P/S
1017.18
P/B
3.13
EV/EBITDA
-6.36
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
-15144.33%
Net Margin
-13938.24%
ROE
-37.70%
ROIC
-42.81%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-94,260,000 · -29.32%
EPS
$-1.68 · 30.58%
Op Income
$-111,558,000
FCF YoY
-19.08%
Performance & Tape
52W High
$13.29
52W Low
$3.56
50D MA
$12.74
200D MA
$8.32
Beta
0.02
Avg Volume
1.07M

Get TickerSpark's AI analysis on ATXS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 23, 26Violin Jonathansell14,100
Jan 23, 26Violin Jonathansell8,333
Jan 23, 26Violin Jonathansell14,100
Jan 23, 26Violin Jonathansell263,321
Jan 23, 26Violin Jonathansell14,166
Jan 23, 26Violin Jonathansell26,550
Jan 23, 26Morabito Christophersell80,000
Jan 23, 26Morabito Christophersell262,500
Jan 23, 26Milne Jill C.sell761,000
Jan 23, 26Milne Jill C.sell4,377
Coverage · ATXS

Our ATXS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ATXS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ATXS report →
Internal Compare

Similar companies

Peers in the same neighborhood.